These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30808458)

  • 1. A case of rifampicin-induced haemolysis.
    Sykes CA; Shepherd J; McGoldrick C; Kennedy N; Raafat A
    Int J Tuberc Lung Dis; 2019 Feb; 23(2):239-240. PubMed ID: 30808458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review.
    Chiba S; Tsuchiya K; Sakashita H; Ito E; Inase N
    Intern Med; 2013; 52(21):2457-60. PubMed ID: 24190152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin-associated acute renal failure and hemolysis: a rather uncommon but severe complication.
    Manika K; Tasiopoulou K; Vlogiaris L; Lada M; Papaemmanouil S; Zarogoulidis K; Kioumis I
    Ren Fail; 2013 Sep; 35(8):1179-81. PubMed ID: 23883374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tolerance of rifampicin in long-term treatment of patients with pulmonary tuberculosis].
    Fokina LV; Vusygina RN; Antosik OD
    Probl Tuberk; 1976 Feb; (21):34-9. PubMed ID: 1264980
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal failure and hemolytic anemia. Rifampicin associated interstitial nephropathy with immune hemolytic anemia].
    Bodmer M; Haschke M; Rätz Bravo AE; Liechti ME
    Praxis (Bern 1994); 2009 Feb; 98(4):179-85. PubMed ID: 19224484
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute renal failure and disseminated intravascular coagulation associated with rifampin in tuberculosis treatment.
    Costiniuk CT; McCarthy AE; Talreja H; Zimmerman D; Liu TT; Owen E; Angel JB
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):421. PubMed ID: 21333117
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
    Beji M; Louzir B; Ben Rhomdane N; Zouari M; Mtimet B; Daghfous J
    Tunis Med; 1995 May; 73(5):201-3. PubMed ID: 9507284
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifapentine vs. rifampicin for the treatment of pulmonary tuberculosis: a systematic review.
    Gao XF; Li J; Yang ZW; Li YP
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):810-9. PubMed ID: 19555529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild haemolysis associated with flu-syndrome during daily rifampicin treatment--a case report.
    Yeo CT; Wang YT; Poh SC
    Singapore Med J; 1989 Apr; 30(2):215-6. PubMed ID: 2609182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous rifampicin administration inducing acute renal failure.
    Bassilios N; Vantelon C; Baumelou A; Deray G
    Nephrol Dial Transplant; 2001 Jan; 16(1):190-1. PubMed ID: 11209029
    [No Abstract]   [Full Text] [Related]  

  • 11. Consider rifampin BUT be cautious.
    Ashkin D; Julien J; Lauzardo M; Hollender E
    Chest; 2006 Dec; 130(6):1638-40. PubMed ID: 17166975
    [No Abstract]   [Full Text] [Related]  

  • 12. Massive haemolysis caused by rifampicin.
    Lakshminarayan S; Sahn SA; Hudson LD
    Br Med J; 1973 May; 2(5861):282-3. PubMed ID: 4704498
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal failure during intermittent rifampicin therapy.
    Chan WC; O'Mahoney MG; Yu DY; Yu RY
    Tubercle; 1975 Sep; 56(3):191-8. PubMed ID: 129898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment.
    Hemanth Kumar AK; Narendran G; Kumar RS; Ramachandran G; Sekar L; Raja K; Swaminathan S
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):805-7. PubMed ID: 26056105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoallergic complication induced by rifampicin with disseminated intravascular coagulation].
    Denis J; Robert A; Johanet C; Homberg JC; Opolon P; Levy VG
    Presse Med; 1983 May; 12(23):1479-81. PubMed ID: 6222344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular haemolysis and renal failure caused by intermittent rifampicin treatment.
    Criel A; Verwilghen RL
    Blut; 1980 Feb; 40(2):147-50. PubMed ID: 7353082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis.
    Luzzati R; Giacomazzi D; Franchi F; Barcobello M; Vento S
    South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477
    [No Abstract]   [Full Text] [Related]  

  • 18. Importance of rifampicin in combined daily/intermittent chemotherapy for tuberculosis.
    Felten MK
    S Afr Med J; 1989 Jun; 75(11):524-6. PubMed ID: 2727841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure and severe thrombocytopenia induced by rifampicin: report of a case.
    Juang YC; Tsao TC; Chiang YC; Lin JL; Tsai YH
    J Formos Med Assoc; 1992 Apr; 91(4):475-6. PubMed ID: 1358323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case Series of Acute Kidney Injury During Anti-tuberculosis Treatment.
    Sakashita K; Murata K; Takahashi Y; Yamamoto M; Oohashi K; Sato Y; Kitazono M; Wada A; Takamori M
    Intern Med; 2019 Feb; 58(4):521-527. PubMed ID: 30333388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.